Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes

AIMS To determine national prevalence of sodium-glucose contransporter-2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP1RA) use among adults with type 2 diabetes mellitus (T2DM). METHODS We studied adults with T2DM and eGFR ≥ 30 mL/min/1.73 m2 who participated in the cross-s…